Modeling the permeability of drug-like molecules through the cell wall of Mycobacterium tuberculosis: an analogue based approach.
暂无分享,去创建一个
G. Narahari Sastry | Sridhara Janardhan | M Ram Vivek | G Narahari Sastry | S. Janardhan | M. Ram Vivek
[1] A K Nandedkar. Comparative study of the lipid composition of particular pathogenic and nonpathogenic species of Mycobacterium. , 1983, Journal of the National Medical Association.
[2] V. Viswanadhan,et al. Pyrid-2-yl and 2-CyanoPhenyl fused heterocyclic compounds as human P2X$$_{3}$$3 inhibitors: a combined approach based on homology modelling, docking and QSAR analysis , 2014, Molecular Diversity.
[3] George Papadatos,et al. The ChEMBL bioactivity database: an update , 2013, Nucleic Acids Res..
[4] G. Madhavi Sastry,et al. Homology modeling of membrane proteins: A critical assessment , 2006, Comput. Biol. Chem..
[5] Christoph A. Sotriffer,et al. MycPermCheck: the Mycobacterium tuberculosis permeability prediction tool for small molecules , 2013, Bioinform..
[6] E. Rubin,et al. Bacterial Growth and Cell Division: a Mycobacterial Perspective , 2008, Microbiology and Molecular Biology Reviews.
[7] R. Todeschini,et al. Molecular Descriptors for Chemoinformatics: Volume I: Alphabetical Listing / Volume II: Appendices, References , 2009 .
[8] Joshua Zhexue Huang,et al. Extensions to the k-Means Algorithm for Clustering Large Data Sets with Categorical Values , 1998, Data Mining and Knowledge Discovery.
[9] G. N. Sastry,et al. Dipeptidyl peptidase IV inhibitors: a new paradigm in type 2 diabetes treatment. , 2014, Current drug targets.
[10] G Narahari Sastry,et al. The efficacy of conceptual DFT descriptors and docking scores on the QSAR models of HIV protease inhibitors. , 2012, Medicinal chemistry (Shariqah (United Arab Emirates)).
[11] P. Brennan. Structure, function, and biogenesis of the cell wall of Mycobacterium tuberculosis. , 2003, Tuberculosis.
[12] Lemont B. Kier,et al. Electrotopological State Indices for Atom Types: A Novel Combination of Electronic, Topological, and Valence State Information , 1995, J. Chem. Inf. Comput. Sci..
[13] A. Kastaniotis,et al. Function of Heterologous Mycobacterium tuberculosis InhA, a Type 2 Fatty Acid Synthase Enzyme Involved in Extending C20 Fatty Acids to C60-to-C90 Mycolic Acids, during De Novo Lipoic Acid Synthesis in Saccharomyces cerevisiae , 2008, Applied and Environmental Microbiology.
[14] Mohammed H Bohari,et al. FDA approved drugs complexed to their targets: evaluating pose prediction accuracy of docking protocols , 2012, Journal of Molecular Modeling.
[15] P J Goodford,et al. Physicochemical-activity relationship in practice. 2. Rational selection of benzenoid substituents. , 1975, Journal of medicinal chemistry.
[16] Mohammed H Bohari,et al. Modeling anti-HIV compounds: the role of analogue-based approaches. , 2012, Current computer-aided drug design.
[17] G Narahari Sastry,et al. Virtual high throughput screening in new lead identification. , 2011, Combinatorial chemistry & high throughput screening.
[18] G. N. Sastry,et al. 2D and 3D quantitative structure-activity relationship studies on a series of bis- pyridinium compounds as choline kinase inhibitors , 2006 .
[19] G. N. Sastry,et al. Choline kinase: an important target for cancer. , 2006, Current medicinal chemistry.
[20] Gregory A. Reichard. SARVision Plus by ChemApps , 2008, J. Chem. Inf. Model..
[21] H. Nikaido,et al. Mycobacterial cell wall: structure and role in natural resistance to antibiotics. , 1994, FEMS microbiology letters.
[22] N. Devaraj,et al. Membrane assembly driven by a biomimetic coupling reaction. , 2012, Journal of the American Chemical Society.
[23] I. Smith,et al. Mycobacterium tuberculosis Pathogenesis and Molecular Determinants of Virulence , 2003, Clinical Microbiology Reviews.
[24] J. Liu,et al. Mycolic Acid Structure Determines the Fluidity of the Mycobacterial Cell Wall* , 1996, The Journal of Biological Chemistry.
[25] Liem Nguyen,et al. Molecular biology of drug resistance in Mycobacterium tuberculosis. , 2013, Current topics in microbiology and immunology.
[26] Gordon M. Crippen,et al. Atomic physicochemical parameters for three-dimensional-structure-directed quantitative structure-activity relationships. 2. Modeling dispersive and hydrophobic interactions , 1987, J. Chem. Inf. Comput. Sci..
[27] C. Choudhury,et al. Structural and Functional Diversities of the Hexadecahydro‐1H‐cyclopenta[a]phenanthrene Framework, a Ubiquitous Scaffold in Steroidal Hormones , 2016, Molecular informatics.
[28] Gibson S. Kibiki,et al. New Drugs against Tuberculosis: Problems, Progress, and Evaluation of Agents in Clinical Development , 2008, Antimicrobial Agents and Chemotherapy.
[29] G. Narahari Sastry,et al. Sequence, Structure, and Active Site Analyses of p38 MAP Kinase: Exploiting DFG-out Conformation as a Strategy to Design New Type II Leads , 2011, J. Chem. Inf. Model..
[30] A Srinivas Reddy,et al. Virtual screening in drug discovery -- a computational perspective. , 2007, Current protein & peptide science.
[31] Richard Svensson,et al. Impact of Stereospecific Intramolecular Hydrogen Bonding on Cell Permeability and Physicochemical Properties , 2014, Journal of medicinal chemistry.
[32] CHUN WEI YAP,et al. PaDEL‐descriptor: An open source software to calculate molecular descriptors and fingerprints , 2011, J. Comput. Chem..
[33] S. Ajmani,et al. Toward a general predictive QSAR model for gamma-secretase inhibitors , 2013, Molecular Diversity.